跨国药企
- multinational pharmaceutical companies
-
他认为,GSK会受到最大的影响,但也推测,其他跨国药企的在华销售额绝对值也将下降10%至20%。
He expected GSK to suffer the greatest impact , but predicted other multinational pharmaceutical companies would also report absolute sales declines in China of 10-20 per cent .
-
全球生物制药价值链中,大型跨国药企的垂直一体化程度很高,因而国内生物制药企业并不嵌入某些环节,而是存在于相对独立的国内价值链。
Global biopharmaceutical value chain is featured with large multinational pharmaceutical companies ' high degree of vertical integration . The domestic biopharmaceutical companies is facing relatively independent domestic value chains .
-
此外,本文还对发生在我国境内的跨国药企召回缺陷药品事件进行了分析。
In addition , some drug recall events by multinational corporations in our country were analyzed .
-
我国药企应对跨国药企在知识产权方面的竞争分析
Analysis of how to deal with transnational pharmaceutical companies for Chinese pharmaceutical companies on the competitions of intellectual property rights